NEW YORK, Aug. 31, 2017 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a boutique securities firm headquartered at the Empire State Building in New York City, is investigating Dimension Therapeutics, Inc. ("Dimension Therapeutics" or the "Company") (NASDAQ: DMTX) relating to the sale of the Company to affiliates of REGENXBIO Inc. (NASDAQ: RGNX). As a result of the merger, Dimension Therapeutics shareholders are only anticipated to receive 0.1573 shares of REGENXBIO in exchange for each share of Dimension Therapeutics.
The investigation focuses on whether Dimension Therapeutics and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company's by 1) failing to conduct a fair process and 2) whether and by how much this proposed transaction undervalues the Company.
Monteverde & Associates PC is a boutique class action securities and consumer litigation law firm that has recovered millions of dollars and iscommitted to protecting shareholders and consumers from corporate wrongdoing. Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct.
If you own common stock in Dimension Therapeutics and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.
Contact: Juan E. Monteverde, Esq. MONTEVERDE & ASSOCIATES PC The Empire State Building 350 Fifth Ave. Suite 4405 New York, NY 10118 United States of America [email protected] Tel: (212) 971-1341
Attorney Advertising. (C) 2017 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.